Structural Bioinformatics of Four Human Aquaporins and Their Water-Soluble QTY Analogs

Human aquaporins (AQPs) are essential membrane channels, yet their inherent hydrophobicity complicates structural and functional studies. We present the systematic application of the QTY code to human AQPs, integrating it with AlphaFold 3 structure prediction to design and validate that four-representative human AQPs (AQP1, AQP3, AQP4, AQP7) can be converted into water-soluble analogs while maintaining their conformation. This approach features a novel platform for editing challenging membrane proteins. The QTY code was applied to the transmembrane regions of the selected four AQPs. Subsequently, the water-soluble QTY analogs of the four AQPs were predicted using AlphaFold 3. The predicted structures were superposed with CyroEM- or X-ray-determined native structures in PyMOL. Further analyses included root-mean-square deviation (RMSD) calculations, visualization of hydrophobic surface reduction, and inspection of conserved protein-ligand binding ability. After applying the QTY code, sequence changes between native AQPs and their QTY analogs was significant (42.86-48.80%). Nevertheless, their structures superposed well in analyses, with only slight deviations (RMSD < 0.6 [A]). In addition, the surface hydrophobicity of all QTY-edited AQPs was significantly reduced. Importantly, molecular contacts between the cholesterol ligand and protein were largely preserved for both native AQP1 and its QTY analog. Finally, all AlphaFold3-predicted structures for AQPs have high confidence values (pLDDT > 90; pTM ~0.83), supporting the reliability of the predicted structures. The findings demonstrate that membrane protein hydrophobicity can be edited and reduced without compromising fold integrity or functional architecture. Integration of the QTY code with AlphaFold 3 affords a high-throughput platform for designing water-soluble, structurally faithful analogs of challenging membrane proteins. Such a strategy can provide a potent platform for detergent-free biochemical studies and water-soluble analogs for therapeutic monoclonal antibody discoveries, thus advancing research of this pharmacologically important protein family.